AU2002352334A1 - Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof - Google Patents
Pharmaceutical composition based on micronized progesterone, preparation method and uses thereofInfo
- Publication number
- AU2002352334A1 AU2002352334A1 AU2002352334A AU2002352334A AU2002352334A1 AU 2002352334 A1 AU2002352334 A1 AU 2002352334A1 AU 2002352334 A AU2002352334 A AU 2002352334A AU 2002352334 A AU2002352334 A AU 2002352334A AU 2002352334 A1 AU2002352334 A1 AU 2002352334A1
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- pharmaceutical composition
- composition based
- micronized progesterone
- micronized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Syngestrets Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title 1
- 229960001207 micronized progesterone Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR01/14653 | 2001-11-13 | ||
| FR0114653A FR2832065B1 (en) | 2001-11-13 | 2001-11-13 | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD THEREOF AND USES THEREOF |
| PCT/FR2002/003879 WO2003041720A1 (en) | 2001-11-13 | 2002-11-13 | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002352334A1 true AU2002352334A1 (en) | 2003-07-24 |
| AU2002352334B2 AU2002352334B2 (en) | 2008-10-23 |
Family
ID=8869332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002352334A Expired AU2002352334B2 (en) | 2001-11-13 | 2002-11-13 | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US20030092691A1 (en) |
| EP (1) | EP1443940B1 (en) |
| KR (1) | KR100911790B1 (en) |
| CN (1) | CN1263453C (en) |
| AT (1) | ATE339958T1 (en) |
| AU (1) | AU2002352334B2 (en) |
| BR (1) | BRPI0214043B8 (en) |
| CY (1) | CY1106293T1 (en) |
| DE (1) | DE60214876T2 (en) |
| DK (1) | DK1443940T3 (en) |
| EA (1) | EA006550B1 (en) |
| ES (1) | ES2272793T3 (en) |
| FR (1) | FR2832065B1 (en) |
| HK (1) | HK1064606A1 (en) |
| HU (1) | HU229341B1 (en) |
| IL (2) | IL161668A0 (en) |
| MA (1) | MA27081A1 (en) |
| NO (1) | NO335044B1 (en) |
| NZ (1) | NZ532659A (en) |
| OA (1) | OA12726A (en) |
| PL (1) | PL206096B1 (en) |
| PT (1) | PT1443940E (en) |
| UA (1) | UA77451C2 (en) |
| WO (1) | WO2003041720A1 (en) |
| ZA (1) | ZA200403288B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2832065B1 (en) * | 2001-11-13 | 2004-11-05 | Besins Int Belgique | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD THEREOF AND USES THEREOF |
| PL2279729T3 (en) * | 2003-07-17 | 2017-02-28 | Banner Life Sciences Llc | Controlled release preparations |
| EA015155B1 (en) * | 2005-05-26 | 2011-06-30 | Тева Вуменс Хелс, Инк. | Oral dosage forms comprising progesterone and methods of making and using the same |
| US8828981B2 (en) * | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
| DE202007019049U1 (en) * | 2007-11-05 | 2010-05-12 | Bayer Schering Pharma Aktiengesellschaft | Use of a gestagen in combination with an estrogen for the prophylaxis of lactose intolerance in oral contraception |
| FR2947178B1 (en) * | 2009-06-29 | 2012-07-06 | Effik | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE AND USES THEREOF |
| CN102091054B (en) * | 2009-12-14 | 2014-04-16 | 浙江爱生药业有限公司 | Progesterone preparation composite and preparation method thereof |
| US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| DK2755498T3 (en) * | 2011-09-15 | 2018-05-22 | Friulchem Spa | COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING |
| WO2013049749A2 (en) | 2011-09-29 | 2013-04-04 | Plx Pharma Inc. | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
| CA2856520C (en) | 2011-11-23 | 2021-04-06 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| KR20170040209A (en) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | Transdermal cream |
| CN107847506A (en) | 2015-06-22 | 2018-03-27 | 来普卡公司 | Orally administered composition and correlation technique containing 17 Gestageno Gadors |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| EP3395332A1 (en) * | 2017-04-28 | 2018-10-31 | Chemo Research, S.L. | Hormone softgel capsules and a process for the preparation thereof |
| US10285998B1 (en) | 2018-04-04 | 2019-05-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
| US11576920B2 (en) | 2019-03-18 | 2023-02-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| JP2023518822A (en) | 2020-03-26 | 2023-05-08 | ピーエルエックス オプコ インコーポレイテッド | Pharmaceutical carrier capable of pH-dependent reconstitution, method of production and method of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2408345A1 (en) * | 1976-11-30 | 1979-06-08 | Besins Jean Louis | NEW COMPOSITION WITH ANTI-CONCEPTIONAL ACTION |
| JPS60258110A (en) * | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | Progesterone emulsified parenteral solution injectable intravenously |
| US5140021A (en) * | 1986-04-16 | 1992-08-18 | Genesis Systems Corporation | Method and dosage form for treatment of premenstrual syndrome |
| DK174724B1 (en) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition |
| IT1256386B (en) * | 1992-11-13 | 1995-12-04 | Luigi Boltri | PHARMACEUTICAL COMPOSITIONS INCLUDING A DRUG, A CROSS-LINKED POLYMERIC SUBSTANCE, AN OIL AND A SURFACTIVE AGENT |
| ES2102793T3 (en) * | 1993-12-22 | 1997-08-01 | Oreal | COSMETIC OR DERMATOLOGICAL POWDER, ITS PREPARATION PROCEDURE AND UTILIZATIONS. |
| FR2747042B1 (en) * | 1996-04-05 | 1998-06-05 | Besins Iscovesco Lab | PROGESTERONE AND OESTRADIOL-BASED MEDICINE |
| GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
| US6861415B2 (en) * | 1996-05-01 | 2005-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | 21-substituted progesterone derivatives as new antiprogestational agents |
| FR2777784B1 (en) * | 1998-04-27 | 2004-03-19 | Arepa | PHARMACEUTICAL COMPOSITION BASED ON ESTROGEN AND PROGESTERONE |
| FR2832065B1 (en) * | 2001-11-13 | 2004-11-05 | Besins Int Belgique | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD THEREOF AND USES THEREOF |
-
2001
- 2001-11-13 FR FR0114653A patent/FR2832065B1/en not_active Expired - Fee Related
-
2002
- 2002-03-14 US US10/097,526 patent/US20030092691A1/en not_active Abandoned
- 2002-11-13 WO PCT/FR2002/003879 patent/WO2003041720A1/en active IP Right Grant
- 2002-11-13 AT AT02788051T patent/ATE339958T1/en active
- 2002-11-13 BR BRPI0214043A patent/BRPI0214043B8/en not_active IP Right Cessation
- 2002-11-13 EP EP02788051A patent/EP1443940B1/en not_active Expired - Lifetime
- 2002-11-13 AU AU2002352334A patent/AU2002352334B2/en not_active Expired
- 2002-11-13 HU HU0401935A patent/HU229341B1/en unknown
- 2002-11-13 CN CNB028224868A patent/CN1263453C/en not_active Expired - Lifetime
- 2002-11-13 DK DK02788051T patent/DK1443940T3/en active
- 2002-11-13 US US10/495,242 patent/US7431941B2/en not_active Expired - Lifetime
- 2002-11-13 EA EA200400668A patent/EA006550B1/en unknown
- 2002-11-13 NZ NZ532659A patent/NZ532659A/en not_active IP Right Cessation
- 2002-11-13 OA OA1200400137A patent/OA12726A/en unknown
- 2002-11-13 PL PL369131A patent/PL206096B1/en unknown
- 2002-11-13 ES ES02788051T patent/ES2272793T3/en not_active Expired - Lifetime
- 2002-11-13 KR KR1020047007199A patent/KR100911790B1/en active IP Right Grant
- 2002-11-13 IL IL16166802A patent/IL161668A0/en unknown
- 2002-11-13 DE DE60214876T patent/DE60214876T2/en not_active Expired - Lifetime
- 2002-11-13 UA UA20040503542A patent/UA77451C2/en unknown
- 2002-11-13 PT PT02788051T patent/PT1443940E/en unknown
-
2004
- 2004-04-29 IL IL161668A patent/IL161668A/en active IP Right Grant
- 2004-04-30 ZA ZA2004/03288A patent/ZA200403288B/en unknown
- 2004-05-04 MA MA27665A patent/MA27081A1/en unknown
- 2004-05-14 NO NO20042002A patent/NO335044B1/en not_active IP Right Cessation
- 2004-10-04 HK HK04107577A patent/HK1064606A1/xx not_active IP Right Cessation
-
2006
- 2006-12-18 CY CY20061101808T patent/CY1106293T1/en unknown
-
2008
- 2008-02-27 US US12/071,822 patent/US7829115B2/en not_active Expired - Lifetime
-
2010
- 2010-11-01 US US12/916,795 patent/US20110135719A1/en not_active Abandoned
-
2012
- 2012-07-05 US US13/542,164 patent/US8435561B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002352334A1 (en) | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | |
| HUP0401935A3 (en) | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | |
| IL163366A (en) | Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions | |
| AU2003230700A1 (en) | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
| AU2003240947A1 (en) | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
| IL165977A (en) | Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same | |
| AU2001237525A1 (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
| AU2001237526A1 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
| AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
| AU2003289641A1 (en) | The novel coumarin-amide derivatives and its preparation, said drug composition and its use | |
| IL161431A0 (en) | beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| AU2001294808A1 (en) | Catecholamine pharmaceutical compositions and methods | |
| IL162185A0 (en) | Phenylpropionate derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| AU2001235737A1 (en) | Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same | |
| AU4996100A (en) | (s,r) formoterol methods and compositions | |
| AU2003251167A1 (en) | Solid dispersion comprising amlodipine, method thereof and pharmaceutical composition comprising the solid dispersion | |
| AU2002360117A1 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
| AU2002341555A1 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
| AU2002334123A1 (en) | Anaesthetic compositions and method for their administration | |
| AU2002308649A1 (en) | Compositions and methods for enhancing drug delivery | |
| AU2570001A (en) | Pharmaceutical composition and method for its manufacture | |
| AU4884701A (en) | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof | |
| HUP0304065A2 (en) | Novel 5-thio-betha-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and use thereof | |
| AU2003267848A1 (en) | Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same | |
| AU2001260083A1 (en) | New pharmaceutical composition and the process for its preparation |